0Suppliers
21Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Inspira Technologies Oxy B.H.N. Ltd. (IINN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships
1Distinct source URLs
4High confidence
0.721Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Inspira Technologies Oxy B.H.N. Ltd. Suppliers

No suppliers on recordInspira Technologies Oxy B.H.N. Ltd. has not yet been matched to upstream suppliers in our database, or is still being processed.

Inspira Technologies Oxy B.H.N. Ltd. Customers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring.…
ABT Abbott Laboratories 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from IINN graph: Reciprocal relationship from BDX graph: Reciprocal relationship from IINN graph: Reciprocal relationship from BDX grap…
BDX Becton, Dickinson and Company 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
BSX Boston Scientific Corporation 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
BSX Boston Scientific Corporation 72% Reciprocal relationship from BSX graph: Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring.…
FSNUY Fresenius SE & Co. KGaA 72% Reciprocal relationship from FSNUY graph: Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitorin…
FSNUY Fresenius SE & Co. KGaA 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
GTLS Chart Industries, Inc. 72% Reciprocal relationship from GTLS graph: Reciprocal relationship from IINN graph: Reciprocal relationship from GTLS graph: Reciprocal relationship from IINN graph: Reciprocal relationship from GTLS g…
GTLS Chart Industries, Inc. 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
JNJ Johnson & Johnson 72% em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product and the disposable unit consist of both …
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring.…
NNDM Nano Dimension Ltd. 72% Reciprocal relationship from NNDM graph: Reciprocal relationship from IINN graph: Reciprocal relationship from NNDM graph: Reciprocal relationship from IINN graph: Reciprocal relationship from NNDM g…
NNDM Nano Dimension Ltd. 72% esults of operations for the years ended December 31, 2025, and December 31, 2024: Year Ended December 31, U.S. dollars in thousands 2025 2024 Increase/Decrease Revenues 289 - 289 Cost of revenues 28…
CLEARX-MEDICAL-LTD CLEARX-MEDICAL-LTD 62% e risks to study subjects outweigh the anticipated benefits. 57 Table of Contents Post-market Regulation After a device is cleared or approved for marketing, numerous and extensive regulatory require…
CME CME Group Inc. 62% Reciprocal relationship from CME graph: Reciprocal relationship from IINN graph: Reciprocal relationship from CME graph: Reciprocal relationship from IINN graph: s, including climate change, energy a…
CME-GROUP CME-GROUP 62% s, including climate change, energy and water use, plastic waste and other sustainability concerns. Concern over climate change may result in new or increased legal and regulatory requirements to red…
DAWSON-JAMES-SECURITIES-INC DAWSON-JAMES-SECURITIES-INC 62% esults of operations for the years ended December 31, 2025, and December 31, 2024: Year Ended December 31, U.S. dollars in thousands 2025 2024 Increase/Decrease Revenues 289 - 289 Cost of revenues 28…
GLO-MED-NETWORKS-INC GLO-MED-NETWORKS-INC 62% t we will incur continued losses for the foreseeable future; ● We could fail to maintain the listing of our securities on Nasdaq, which could seriously harm the liquidity of our shares and our abilit…
INSENSE-MEDICAL-LTD INSENSE-MEDICAL-LTD 62% e risks to study subjects outweigh the anticipated benefits. 57 Table of Contents Post-market Regulation After a device is cleared or approved for marketing, numerous and extensive regulatory require…
YA-II-PN-LTD YA-II-PN-LTD 62% esults of operations for the years ended December 31, 2025, and December 31, 2024: Year Ended December 31, U.S. dollars in thousands 2025 2024 Increase/Decrease Revenues 289 - 289 Cost of revenues 28…

Inspira Technologies Oxy B.H.N. Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IINN-DEBT-10216 Warrants outstanding: 1.28 90% xbrl warrant detail from xbrl 2025-12-31.
IINN-DEBT-10217 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
IINN-DEBT Debt stack $480,000 90% Market cache reports total debt of $480,000.

Inspira Technologies Oxy B.H.N. Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Inspira Technologies Oxy B.H.N. Ltd..

Inspira Technologies Oxy B.H.N. Ltd. Ownership

HolderNameConfidenceEvidence
IINN-OWNER-ARMISTICE-CAPITAL-LLC ARMISTICE CAPITAL, LLC 90% 13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 20 tracked holders.

Inspira Technologies Oxy B.H.N. Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GCTK GlucoTrack, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
CSTE Caesarstone Ltd. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ANGO AngioDynamics, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ALVO Alvotech 100.00 2
GRAL GRAIL, Inc. 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
🔐
IINN
Unlock IINN Supply Chain Data
Verified relationships include:
ABTAbbott LaboratoriesCustomer72%
ABTAbbott LaboratoriesCustomer72%
+21 more relationships locked
Subscribe — View plans →